disclosed is an apparatus and system for monitoring drug regimen compliance , the system utilizing a radio frequency identification tag affixed to a pharmaceutical agent and a wearable rfid reader that identifies a patient . the rfid tag identifies the pharmaceutical agent and the rfid reader wirelessly communicates with a central monitoring system upon ingestion of the pharmaceutical agent .